SENSITIVITY OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS TO VARIATION IN MODEL PARAMETERS - METHYLENE-CHLORIDE

被引:65
|
作者
CLEWELL, HJ
LEE, TS
CARPENTER, RL
机构
[1] USN,MED RES INST DETACHMENT TOXICOL,2612 5TH ST,WRIGHT PATTERSON AFB,OH 45433
[2] CLEMENT ASSOCIATES,RUSHTON,LA
[3] WESTERN ILLINOIS UNIV,DEPT MATH,MACOMB,IL 61455
关键词
LIVER; LUNG; METHYLENE CHLORIDE; PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS; PARAMETER SIGNIFICANCE; SENSITIVITY ANALYSIS;
D O I
10.1111/j.1539-6924.1994.tb00268.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The parameters in a physiologically based pharmacokinetic (PBPK) model of methylene chloride were varied systematically, and the resulting variation in a number of model outputs was determined as a function of time for mice and humans at several exposure concentrations. The importance of the various parameters in the model was highly dependent on the conditions (concentration, species) for which the simulation was performed and the model output (dose surrogate) being considered. Model structure also had a significant impact on the results. For sensitivity analysis, particular attention must be paid to conservation equations to ensure that the variational calculations do not alter mass balance, introducing extraneous effects into the model. All of the normalized sensitivity coefficients calculated in this study ranged between -1.12 and 1, and most were much less than 1 in absolute value, indicating that individual input errors are not greatly amplified in the outputs. In addition to ranking parameters in terms of their impact on model predictions, time-dependent sensitivity analysis can also be used as an aid in the design of experiments to estimate parameters by predicting the experimental conditions and sampling points which will maximize parameter identifiability.
引用
收藏
页码:521 / 531
页数:11
相关论文
共 50 条
  • [1] INCORPORATION OF INVITRO ENZYME DATA INTO THE PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR METHYLENE-CHLORIDE - IMPLICATIONS FOR RISK ASSESSMENT
    REITZ, RH
    MENDRALA, AL
    PARK, CN
    ANDERSEN, ME
    GUENGERICH, FP
    TOXICOLOGY LETTERS, 1988, 43 (1-3) : 97 - 116
  • [2] INVITRO METABOLISM OF METHYLENE-CHLORIDE IN HUMAN AND ANIMAL-TISSUES - USE IN PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS
    REITZ, RH
    MENDRALA, AL
    GUENGERICH, FP
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 97 (02) : 230 - 246
  • [3] An introduction to physiologically-based pharmacokinetic models
    Upton, Richard N.
    Foster, David J. R.
    Abuhelwa, Ahmad Y.
    PEDIATRIC ANESTHESIA, 2016, 26 (11) : 1036 - 1046
  • [4] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ACETONE
    KUMAGAI, S
    MATSUNAGA, I
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1995, 52 (05) : 344 - 352
  • [5] Have physiologically-based pharmacokinetic models delivered?
    Edginton, Andrea N.
    Joshi, Ghanashyam
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (08) : 929 - 934
  • [6] Applications of minimal physiologically-based pharmacokinetic models
    Yanguang Cao
    William J. Jusko
    Journal of Pharmacokinetics and Pharmacodynamics, 2012, 39 : 711 - 723
  • [7] Examination of Physiologically-Based Pharmacokinetic Models of Rosuvastatin
    Bowman, Christine M.
    Ma, Fang
    Mao, Jialin
    Chen, Yuan
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (01): : 5 - 17
  • [8] Applications of minimal physiologically-based pharmacokinetic models
    Cao, Yanguang
    Jusko, William J.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (06) : 711 - 723
  • [9] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS IN DEVELOPMENTAL TOXICOLOGY
    FLAHERTY, EJ
    RISK ANALYSIS, 1994, 14 (04) : 605 - 611
  • [10] PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE
    ANDERSEN, ME
    CLEWELL, HJ
    GARGAS, ML
    SMITH, FA
    REITZ, RH
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) : 185 - 205